scholarly journals Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for Septic Shock

2021 ◽  
Author(s):  
Chieko Mitaka ◽  
Makio Kusaoi ◽  
Izumi Kawagoe ◽  
Daizoh Satoh
Keyword(s):  
Septic Shock ◽  
Polymyxin B ◽  
Direct Hemoperfusion

Clinical Effects and Outcomes After Polymyxin B–Immobilized Fiber Column Direct Hemoperfusion Treatment for Septic Shock in Preterm Neonates*

2020 ◽  
Vol 21 (2) ◽  
pp. 156-163 ◽  
Author(s):  
Naoto Nishizaki ◽  
Taichi Hara ◽  
Kaoru Obinata ◽  
Mayu Nakagawa ◽  
Toshiaki Shimizu
Keyword(s):  
Septic Shock ◽  
Polymyxin B ◽  
Preterm Neonates ◽  
Clinical Effects ◽  
Direct Hemoperfusion

Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber

2016 ◽  
Vol 20 (4) ◽  
pp. 368-375 ◽  
Author(s):  
Itaru Ebihara ◽  
Kouichi Hirayama ◽  
Miho Nagai ◽  
Eri Shiina ◽  
Megumi Koda ◽  
...  
Keyword(s):  
Septic Shock ◽  
Acute Kidney Injury ◽  
Kidney Injury ◽  
Polymyxin B ◽  
Direct Hemoperfusion

Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock

2016 ◽  
Vol 20 (1) ◽  
pp. 71-75 ◽  
Author(s):  
Shinya Chihara ◽  
Yoshiki Masuda ◽  
Hiroomi Tatsumi ◽  
Kota Nakano ◽  
Tomokazu Shimada ◽  
...  
Keyword(s):  
Septic Shock ◽  
Polymyxin B ◽  
Direct Hemoperfusion

Treatment of Pyonephritis Complicated by Septic Shock Using Extracorporeal Device Polymyxin B-Hemoperfusion

2020 ◽  
Vol 49 (5) ◽  
pp. 627-630
Author(s):  
Gabriele Amoruso ◽  
Nicola Di Venosa ◽  
Luigi Rizzi ◽  
Gianna Lupo ◽  
Armando Gisotti ◽  
...  
Keyword(s):  
Septic Shock ◽  
Treatment Method ◽  
Polymyxin B ◽  
Surviving Sepsis Campaign ◽  
Direct Hemoperfusion ◽  
Gram Negative ◽  
Polymyxin B Hemoperfusion ◽  
Established Treatment

Direct hemoperfusion using polymyxin B-immobilized fiber (PMX-DHP) is an established treatment method for septic shock caused by Gram-negative infections. We report one instance in which PMX-DHP therapy has been used successfully in a 33-year-old woman with septic shock from urosepsis. Although there is lack of recommendations in latest Surviving Sepsis Campaign Guidelines, evidence of PMX-DHP efficacy in this subset of patients is growing.

Sign in / Sign up

Export Citation Format

Share Document